09/12/22 7:15 AMNasdaq : ADGI, IVVD covid-19Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron VariantsIntegrated discovery platform is producing a stream of candidate antibodies demonstrating broad in vitro neutralization against past variants of concern (e.g., D614G, beta, delta) and Omicron sublineages BA.1, BA.2, BA.4, BA.5 and BA.2.75, as well as SARS-CoV-1 Antibodies target highly conservedRHEA-AIneutral
09/12/22 7:00 AMNasdaq : ADGI, IVVD Adagio Therapeutics Announces Corporate Name Change to InvivydNew name reflects Company focus on leveraging its integrated discovery platform to generate anti-viral antibodies that transcend the limits of naturally occurring immunity The Invivyd corporate mission is to provide antibody solutions that provide superior protection against viral diseases,RHEA-AIneutral
